JOURNAL CLUB · GO DEEPER
Oei JL, Kirby A, Travadi J, et al. JAMA. 2026;335(6):523-530. doi:10.1001/jama.2025.23327. An unblinded, multinational randomised trial.
Death or brain injury by 36 weeks was 46.9% (60%) vs 47.8% (30%). RR 0.98 (95% CI 0.89-1.09).
Death 15.4% vs 15.8%; brain injury 42.4% vs 43.2%. No difference in severe IVH or PVL.
6.4% vs 2.4%. A secondary finding of uncertain significance, but not reassuring for higher starting oxygen.
FiO2 was escalated to 1.0 in 38% (60% group) vs 41% (30% group). 94% received the allocated starting FiO2.
For babies under 29 weeks, starting at 60% rather than 30% did not reduce death or brain injury. Consistent across gestation, steroid exposure, sex and consent type.
Extremely preterm births are rare in a special care nursery, but they happen, often before NETS arrives. TORPIDO 30/60 shows that starting at 60% rather than 30% oxygen does not improve survival without brain injury, and may increase ventriculomegaly. Starting low (around 30%) and titrating to target saturations remains appropriate - follow your local and ANZCOR guidance. What matters most: get a pulse oximeter on early, watch the heart rate, titrate promptly to targets and ventilate effectively. About 4 in 10 babies needed 100% oxygen whichever group they were in.
What starting oxygen does our unit use for a 26-week baby, and where is that written down?
About 40% of babies were escalated to 100% oxygen. What does that tell us about the starting point versus titration?
How should we interpret the higher rate of ventriculomegaly with 60%, given a neutral primary outcome?
Taken with AIROPLANE, what delivery-room oxygen approach would you teach a new RMO?
Take-home message: In babies born at 23-28 weeks, starting resuscitation at 60% rather than 30% oxygen did not change death or brain injury by 36 weeks (about 47% in both groups), and ventriculomegaly was more common with 60%. Start low, titrate promptly to target saturations, and ventilate effectively.
For educational purposes only. Journal club appraisal - figures paraphrased from the published trial; read the full article for complete data. Always align practice to your local guidelines.